Wall Street Experts
ver. ZuMIgo(08/25)
Corvus Pharmaceuticals, Inc.
Rachunek Zysków i Strat
Przychody TTM (mln): 0
EBIT TTM (mln): -25
index |
0 |
1 |
2 |
3 |
4 |
5 |
6 |
7 |
8 |
9 |
10 |
Rok finansowy |
2014 |
2015 |
2016 |
2017 |
2018 |
2019 |
2020 |
2021 |
2022 |
2023 |
2024 |
Przychód (mln) |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
Przychód Δ r/r |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
Marża brutto |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
-inf% |
-inf% |
-inf% |
-inf% |
-inf% |
0.0% |
EBIT (mln) |
-0 |
-14 |
-37 |
-57 |
-49 |
-49 |
-44 |
-39 |
-33 |
-23 |
-28 |
EBIT Δ r/r |
0.0% |
7740.1% |
168.5% |
52.9% |
-12.9% |
-0.7% |
-10.4% |
-11.7% |
-15.7% |
-28.1% |
17.7% |
EBIT (%) |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
nan |
Koszty finansowe (mln) |
0 |
0 |
1 |
0 |
2 |
2 |
1 |
0 |
1 |
2 |
2 |
EBITDA (mln) |
0 |
-14 |
-37 |
-57 |
-49 |
-49 |
-44 |
-43 |
-33 |
-23 |
-28 |
EBITDA(%) |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
nan |
Podatek (mln) |
0 |
-0 |
-1 |
-1 |
2 |
-3 |
-1 |
-5 |
9 |
0 |
0 |
Zysk Netto (mln) |
-0 |
-31 |
-36 |
-56 |
-47 |
-44 |
-5 |
-38 |
-50 |
-27 |
-62 |
Zysk netto Δ r/r |
0.0% |
17740.9% |
16.1% |
53.0% |
-15.7% |
-6.8% |
-89.0% |
692.0% |
31.0% |
-46.0% |
130.5% |
Zysk netto (%) |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
nan |
EPS |
-1.03 |
-1.54 |
-2.36 |
-2.72 |
-1.71 |
-1.49 |
-0.16 |
-0.91 |
-1.08 |
-0.56 |
-1.02 |
EPS (rozwodnione) |
-1.03 |
-1.54 |
-2.36 |
-2.72 |
-1.71 |
-1.49 |
-0.16 |
-0.91 |
-1.08 |
-0.56 |
-1.02 |
Ilośc akcji (mln) |
0 |
20 |
15 |
20 |
28 |
29 |
29 |
42 |
47 |
48 |
61 |
Ważona ilośc akcji (mln) |
0 |
20 |
15 |
20 |
28 |
29 |
29 |
42 |
47 |
48 |
61 |
Waluta |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |